Reduction of methylphenidate induced anxiety, depression and cognition impairment by various doses of venlafaxine in rat
Background: Methylphenidate (MPH) is a neural stimulant agent, which its neurochemical and behavioral effect remain unclear. Venlafaxine is a serotonin-norepinephrine reuptake inhibitor antidepressant, which was used for management of depression and anxiety. In this study, protective effects of venl...
Main Authors: | Majid Motaghinejad, Manijeh Motevalian, Andia Ebrahimzadeh, Setare Farokhi larijani, Zohreh Khajehamedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | International Journal of Preventive Medicine |
Subjects: | |
Online Access: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2015;volume=6;issue=1;spage=52;epage=52;aulast=Motaghinejad |
Similar Items
-
Preventive Effect of Central Administration of Venlafaxine on Morphine Physical Dependence, Nociception, and Blood Cortisol Level in Rat
by: Majid Motaghinejad, et al.
Published: (2014-01-01) -
Clinical effect of venlafaxine combined with methylphenidate hydrochloride on narcolepsy
by: Bin YAN, et al.
Published: (2013-11-01) -
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
by: J.G. Santos Junior, et al.
Published: (2002-04-01) -
Metabolic Effects of Two Different Doses of Venlafaxine Therapy on Rats
by: Annamária Imre, et al.
Published: (2015-09-01) -
Neuroleptic Malignant Syndrome After the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder
by: Tsung-Chien Lu, et al.
Published: (2006-01-01)